Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and AI technology company, announced updates on the regulatory and initial deployment activities for its telehealth platform in Venezuela. The company is advancing early-stage deployment, testing, and refinement of the platform, which is accessible through its digital interface at latamedai.org. Current efforts focus on evaluating system performance, user workflows, and operational capabilities.
The platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics. In parallel, the company is working with Venezuela's Ministerio del Poder Popular para la Salud and the Servicio Autónomo de Contraloría Sanitaria (SACS) to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. Management anticipates completing the permitting process in the near term, though no assurances are provided.
CEO Dr. Kevin Rodan Levy emphasized that the phase of deployment, testing, and regulatory alignment is crucial for building a scalable telehealth platform capable of operating in real-world healthcare environments. The company expects a full launch upon receiving all regulatory approvals. This initiative represents a foundational step toward broader deployment across Latin America, addressing the growing demand for modernized healthcare delivery systems in emerging markets.
Catalyst Crew Technologies is actively transitioning into AI-enabled healthcare, focusing on telehealth infrastructure, remote patient monitoring, and data analytics. For more information, visit catalystcrewai.com or review SEC filings at sec.gov.
